Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion

<div>Comparison of preoperative tumor marker AFP, tumor size, and number of patients with liver cirrhosis in each group. Note: (a), (b), and (c) showed the comparisons of preoperative tumor marker AFP, tumor size, and number of patients with liver cirrhosis in the four groups.</div>

Disease Markers

fig5

Figure 5

Figure 5: Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion 

Figure 5 | Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion 